NR3C1 and myeloid sarcoma: We also observed a reduced expression of the GR‐induced genes DUSP1 and TSC22D3 in the blood of relapsing GC‐resistant patients with MS compared to relapsing GC‐sensitive patients with MS, as demonstrated by others.33, 34